Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis

Background: Psoriasis goes beyond skin, intertwining with body systems, notably connecting to nonalcoholic fatty liver disease (NAFLD). This study aims to explore the predictive potential: liver function tests and IL-6 as early markers for non-alcoholic fatty liver disease in psoriasis patients. ...

Full description

Bibliographic Details
Main Authors: Tadamun Adbullah, Alyaa Ali, Saad Ahmed Ali Jadoo, Ismail Latif, Khudhair Khalaf Alkayally Alkayally, Raghad Salman
Format: Article
Language:English
Published: Journal of Ideas in Health 2023-12-01
Series:Journal of Ideas in Health
Subjects:
Online Access:http://www.jidhealth.com/index.php/jidhealth/article/view/321
_version_ 1827380710729580544
author Tadamun Adbullah
Alyaa Ali
Saad Ahmed Ali Jadoo
Ismail Latif
Khudhair Khalaf Alkayally Alkayally
Raghad Salman
author_facet Tadamun Adbullah
Alyaa Ali
Saad Ahmed Ali Jadoo
Ismail Latif
Khudhair Khalaf Alkayally Alkayally
Raghad Salman
author_sort Tadamun Adbullah
collection DOAJ
description Background: Psoriasis goes beyond skin, intertwining with body systems, notably connecting to nonalcoholic fatty liver disease (NAFLD). This study aims to explore the predictive potential: liver function tests and IL-6 as early markers for non-alcoholic fatty liver disease in psoriasis patients.  Methods: From March to November 2023, a case-control study was performed at the dermatological outpatient clinic of Baquba Teaching Hospital, Iraq. Individuals with confirmed psoriasis and those without underwent comprehensive clinical history and overall health examinations. The diagnosis of non-alcoholic fatty liver disease (NAFLD) was established using the Fatty Liver Index (FLI). Results: Among the 290 participants in this study, 103 with confirmed psoriasis displayed a Fatty Liver Index (FLI) score >60, indicative of non-alcoholic fatty liver disease (NAFLD). The control group, comprising 101 individuals without psoriasis or NAFLD, provided a baseline for comparison. The mean ages were 32.5 ± 16.2 and 31.5 ± 14.3 years for the case and control groups, respectively. Notably, the case group exhibited significantly higher mean ± SD levels of ALT and AST (61 ± 29 vs. 33 ± 17 U/L, p < 0.0001) and (55 ± 27 vs. 25 ± 15 U/L, p < 0.0001), respectively. Moreover, FLI criteria were markedly elevated in the case group (p = 0.0007, p = 0.0005, p < 0.0001, and p < 0.0001, respectively), and IL-6 levels were significantly higher (p = 0.0003). Conclusion: The results proposed that liver function tests and IL-6 could act as early predictors for the detection of non-alcoholic fatty liver disease among individuals grappling with psoriasis.
first_indexed 2024-03-08T13:37:55Z
format Article
id doaj.art-0566c5b21334407497e4d00ad11155f9
institution Directory Open Access Journal
issn 2645-9248
language English
last_indexed 2024-03-08T13:37:55Z
publishDate 2023-12-01
publisher Journal of Ideas in Health
record_format Article
series Journal of Ideas in Health
spelling doaj.art-0566c5b21334407497e4d00ad11155f92024-01-16T13:41:20ZengJournal of Ideas in HealthJournal of Ideas in Health2645-92482023-12-016410.47108/jidhealth.Vol6.Iss4.321Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis Tadamun Adbullah0Alyaa Ali1Saad Ahmed Ali Jadoo2Ismail Latif3Khudhair Khalaf Alkayally Alkayally4Raghad Salman5Department of Microbiology, College of Medicine, University of Diyala, Diyala, IraqDepartment of Microbiology, College of Medicine University of Diyala, Diyala, IraqDepartment of Family and Community Medicine, College of Medicine, University of Diyala, Diyala, IraqMedical Immunology, College of Medicine, University of Diyala, Diyala, IraqDepartment of Medicine, College of Medicine, University of Diyala, Diyala, Iraq.Department of Microbiology, College of Medicine University of Diyala, Diyala, Iraq Background: Psoriasis goes beyond skin, intertwining with body systems, notably connecting to nonalcoholic fatty liver disease (NAFLD). This study aims to explore the predictive potential: liver function tests and IL-6 as early markers for non-alcoholic fatty liver disease in psoriasis patients.  Methods: From March to November 2023, a case-control study was performed at the dermatological outpatient clinic of Baquba Teaching Hospital, Iraq. Individuals with confirmed psoriasis and those without underwent comprehensive clinical history and overall health examinations. The diagnosis of non-alcoholic fatty liver disease (NAFLD) was established using the Fatty Liver Index (FLI). Results: Among the 290 participants in this study, 103 with confirmed psoriasis displayed a Fatty Liver Index (FLI) score >60, indicative of non-alcoholic fatty liver disease (NAFLD). The control group, comprising 101 individuals without psoriasis or NAFLD, provided a baseline for comparison. The mean ages were 32.5 ± 16.2 and 31.5 ± 14.3 years for the case and control groups, respectively. Notably, the case group exhibited significantly higher mean ± SD levels of ALT and AST (61 ± 29 vs. 33 ± 17 U/L, p < 0.0001) and (55 ± 27 vs. 25 ± 15 U/L, p < 0.0001), respectively. Moreover, FLI criteria were markedly elevated in the case group (p = 0.0007, p = 0.0005, p < 0.0001, and p < 0.0001, respectively), and IL-6 levels were significantly higher (p = 0.0003). Conclusion: The results proposed that liver function tests and IL-6 could act as early predictors for the detection of non-alcoholic fatty liver disease among individuals grappling with psoriasis. http://www.jidhealth.com/index.php/jidhealth/article/view/321P. aeruginosa, ERIC-PCR, ESBLs, fingerprint analysis
spellingShingle Tadamun Adbullah
Alyaa Ali
Saad Ahmed Ali Jadoo
Ismail Latif
Khudhair Khalaf Alkayally Alkayally
Raghad Salman
Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
Journal of Ideas in Health
P. aeruginosa, ERIC-PCR, ESBLs, fingerprint analysis
title Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
title_full Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
title_fullStr Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
title_full_unstemmed Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
title_short Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis
title_sort bridging the diagnostic gap liver function tests and il 6 as potential early predictors of non alcoholic fatty liver disease in psoriasis
topic P. aeruginosa, ERIC-PCR, ESBLs, fingerprint analysis
url http://www.jidhealth.com/index.php/jidhealth/article/view/321
work_keys_str_mv AT tadamunadbullah bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis
AT alyaaali bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis
AT saadahmedalijadoo bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis
AT ismaillatif bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis
AT khudhairkhalafalkayallyalkayally bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis
AT raghadsalman bridgingthediagnosticgapliverfunctiontestsandil6aspotentialearlypredictorsofnonalcoholicfattyliverdiseaseinpsoriasis